Evidence map›Paper›PMID 11027214›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2000

NF-kappa B signaling promotes both cell survival and neurite process formation in nerve growth factor-stimulated PC12 cells.

E D Foehr, X Lin, A O'Mahony, R Geleziunas, R A Bradshaw, W C Greene

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 150 citations in OpenAlex.

  1. Nerve growth factor receptor (NGFR): A key player in glioblastoma progression.Biochimica et biophysica acta. Reviews on cancer · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Oxytocin and microglia in the development of social behaviour.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2022
    Review
  6. Review
  7. Long Non-coding RNAs (lncRNAs), A New Target in Stroke.Cellular and molecular neurobiology · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Inferring genome-wide functional modulatory network: a case study on NF-κB/RelA transcription factor.Journal of computational biology : a journal of computational molecular cell biology · 2015
    Article
  16. Cytokine Spatzle binds to the Drosophila immunoreceptor Toll with a neurotrophin-like specificity and couples receptor activation.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  17. Article
  18. Article
  19. The effects of estrogen in ischemic stroke.Translational stroke research · 2013
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

E D FoehrGladstone Institute of Virology and Immunology, Department of Medicine, University of California, San Francisco, San Francisco, California 94141-9100, USA.
X Lin
A O'Mahony
R Geleziunas
R A Bradshaw
W C Greene
Institute of Virology of the Slovak Academy of Sciences · SKUniversity of California, San Francisco · USUniversity of California, Irvine · US

Funding

UCSF-GIVI CENTER FOR AIDS RESEARCHP30MH059037 · NIMH · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI FEINBERG, MARK A · 1998 to 2001
$4.9M
STRUCTURE &FUNCTION OF NERVE GROWTH FACTORR01AG009735 · NIA · UNIVERSITY OF CALIFORNIA IRVINE · PI BRADSHAW, RALPH A · 1990 to 2000
$94k
NIA NIH HHS AG 9735NIMH NIH HHS P30-MH 59037
6 · The paper itself

Abstract

Nerve growth factor binds to the TrkA and p75(NTR) (p75) and generates signals leading to neuronal cell survival, differentiation, and programmed cell death. Here we describe a series of experiments involving selective activation of either TrkA or p75 in which distinct cell-signaling intermediates promote different cellular consequences. We analyzed pheochromocytoma 12 (PC12) cells stably expressing chimeras consisting of the extracellular domain of PDGF receptor (PDGFR) fused to the transmembrane and cytoplasmic segments of p75 or TrkA. Because PC12 cells lack endogenous PDGFR, addition of PDGF to these cell lines permits selective activation of the p75 or TrkA responses without stimulating endogenous receptors. Although both p75 and TrkA activated nuclear factor-kappaB (NF-kappaB), we show that distinct proximal-signaling intermediates are used by each receptor. A dominant-negative mutant of TRAF6 blocked p75- but not TrkA-mediated induction of NF-kappaB. Conversely a dominant-negative mutant of Shc inhibited TrkA but not p75 activation of NF-kappaB. Both of these distinct signaling pathways subsequently converge, leading to activation of the IkappaB kinase complex. Moreover, the activation of NF-kappaB by these distinct pathways after stimulation of either TrkA or p75 leads to different physiological consequences. Blocking p75-mediated activation of NF-kappaB by ecdysone-inducible expression of a nondegradable mutant of IkappaBalpha significantly enhanced apoptosis. In contrast, blocking NF-kappaB induction via TrkA significantly inhibited neurite process formation in PC12 cells. Together these findings indicate that, although both of these receptors lead to the activation of NF-kappaB, they proceed via distinct proximal-signaling intermediates and contribute to different cellular outcomes.

Indexed as

I-kappa B ProteinsAnimalsApoptosisCell DifferentiationCell SurvivalDNA-Binding ProteinsGenes, DominantNerve Growth FactorNeuritesNF-kappa BNF-KappaB Inhibitor alphaPC12 CellsPlatelet-Derived Growth FactorRatsReceptor, Nerve Growth FactorReceptor, trkADNA-Binding ProteinsI-kappa B ProteinsNerve Growth FactorNF-kappa BNF-KappaB Inhibitor alphaNfkbia protein, ratPlatelet-Derived Growth FactorReceptor, Nerve Growth FactorReceptor, trkARecombinant Fusion ProteinsTumor Necrosis Factor-alpha

Identifiers

PMID11027214
PMCPMC6772878
OpenAlexW1552943795

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.